Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Zhejiang UniversityActive in the last 2 years

Jinhui Zhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0136-1150; OpenAlex author ID A5102008090, A5134126250. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
16
Papers, trials and grants by year

2018: 2 papers · 2019: 1 paper · 2020: 2 papers · 2021: none · 2022: 3 papers · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 10

  1. CDC6/THBS1 accelerates pancreatic cancer progression via AKT-mediated glycolytic reprogramming. Last author DOI 10.1038/s41419-026-08758-2↗
  2. Quantifying the impact of metronomic chemotherapy chemo-switch regimen and the sequencing of chemotherapy and radiotherapy on pancreatic ductal adenocarcinoma … Co-author DOI 10.1016/j.jtbi.2024.112033↗
  3. Research progress on microRNAs as molecular markers in pancreatic cancer: a narrative review. Last author DOI 10.21037/jgo-22-577↗
  4. MiR-520a-5p/PPP5C regulation pattern is identified as the key to gemcitabine resistance in pancreatic cancer. Last author DOI 10.3389/fonc.2022.903484↗
  5. Application of artificial intelligence to pancreatic adenocarcinoma. Last author DOI 10.3389/fonc.2022.960056↗
  6. The Serum MicroRNA Signatures for Pancreatic Cancer Detection and Operability Evaluation. Last author DOI 10.3389/fbioe.2020.00379↗
  7. The Key Genes for Perineural Invasion in Pancreatic Ductal Adenocarcinoma Identified With Monte-Carlo Feature Selection Method. Co-author DOI 10.3389/fgene.2020.554502↗
  8. SPOP suppresses pancreatic cancer progression by promoting the degradation of NANOG. Co-author DOI 10.1038/s41419-019-2017-z↗
  9. Gemcitabine induces apoptosis and autophagy via the AMPK/mTOR signaling pathway in pancreatic cancer cells. Co-author DOI 10.1002/bab.1657↗
  10. Knockdown of serine/threonine protein phosphatase 5 enhances gemcitabine sensitivity by promoting apoptosis in pancreatic cancer cells in vitro. Co-author DOI 10.3892/ol.2018.8363↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ruibiao Fu · 3 shared papers, 2022 · strength 0.51
  2. Sheng Li · 1 shared paper, 2025 · strength 0.37
  3. Xu Wang · 1 shared paper, 2025 · strength 0.37
  4. Mengqiu Yin · 1 shared paper, 2026 · strength 0.36
  5. Yan Chen · 2 shared papers, 2020–2022 · strength 0.29
  6. Qiuliang Yan · 2 shared papers, 2020 · strength 0.24
  7. Jiale Zhou · 2 shared papers, 2018 · strength 0.18
  8. Yun Jin · 2 shared papers, 2018 · strength 0.18
  9. Bin Yang · 1 shared paper, 2022 · strength 0.17
  10. Xi Chen · 1 shared paper, 2022 · strength 0.16
  11. Jianwei Wang · 1 shared paper, 2020 · strength 0.13
  12. Tao Huang · 1 shared paper, 2020 · strength 0.13
  13. Dandan Hu · 1 shared paper, 2020 · strength 0.11
  14. Lei Yao · 1 shared paper, 2019 · strength 0.09
  15. Peng Tan · 1 shared paper, 2019 · strength 0.09
  16. Yan Chen · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.